Pada setiap pemberian obat kepada pasien reaksi simpang obat harus selalu dipertimbangkan. Pajanan ulang dengan obat penyebab dapat menyebabkan erupsi obat menjadi lebih berat daripada bentuk klinis sebelumnya, bahkan dapat mengancam jiwa. Penelitian retrospektif yang dilaksanakan selama 5 tahun (1998 -2002) (1998)(1999)(2000)(2001)(2002) 
Drug eruption or cutaneous adverse drug eruption (CADR) must always consider in patient management. CADR are a frequent problem in dermatology, especially in finding the causative drug, due to multiple drug regimens frequently prescribe by the physician.
An allergic reaction involves immunological mechanism and the clinical manifestation are often thought to be combination of different Coombs and Gell type reactions. 1 Oral challenge is still the gold standard in investigating the cause of CADR. In severe cases of CADR performing an oral challenge test is dangerous and is not excepted from the ethical point. 2 Skin testing with drug, as an alternative methods, has been one of the main interests during the past 10 to 15 years. 3 To find the causative drugs is not only important to the re-exposing of the drug in the future but also to the physician to find an alternative drug to be given to the patient. 
METHODS
A retrospective study of drug eruption was conducted on patients who underwent skin test during 1998 -2002 at sub-department of Allergy Immunology, Department of Dermatovenereology, Faculty of Medicine, University of Indonesia / Dr. Cipto Mangunkusumo Hospital, Jakarta. A closed patch test was performed with the suspected drug on the back using Finn Chamber on Scanpor tape (Epitest, Tuusula, Finland). Reading was performed on day 2, day 3, and day 4. The result was reported based on ICDRG criteria. 5, 6 The concentration of the drug for patch test was made according to de Groot (1986). 7 Negative patch test result, was followed by prick test with the suspected drug.
For prick test the drug was sequential diluted at 10 -2 and 10 -1 . Reaction are considered positive when a wheal with diameter 3 mm larger than negative control (0.9% saline) is present 20 minutes later. Positive control was performed with histamine (10mg/ml).
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RESULTS
Seven hundred forty six (746) patients were diagnosed as drug eruption during the period of 1998 -2002. Fixed drug eruption (FDE) were the most common (21.99%) clinical type found, followed by urticaria (11.80); eczematous eruption (10.72); exanthema eruption (7.51%); and erythroderma (7.51%) ( Table 1) .
Skin test were done in 125 patients and 43 (34.4%) gave positive result. The 5 prominent positive patch test results were obtained from erythema multiforme 66.7%, erythroderma 60%, erythema 57.1%, eczematous eruption 45.5%, papular eruption 33.3%. The 5 prominent positive SPT results were erythema 66.7%, exanthematous eruption 50%, erythroderma 42.9%, urticaria 42.1%, S-J syndr/TEN 37.5% as shown on Table 2 . The most frequent drugs that give positive results on overall skin test are shown on Table 3 . Confirmation of the skin test with oral provocation test was conducted in several mild urticaria and FDE patients and the results are shown on Table 4 . 
DISCUSSION
To evaluate the cause of systemic drug eruption oral provocation test may provoked the same or even more worse reaction, and in severe cases it is not possible from the ethical point. 2, 8 Skin testing (patch test, skin prick test and intradermal test) with the suspected compound has been reported to be helpful in determining the cause of CADR and in studying the pathophysiological mechanism involved in these reaction. 5 In performing skin test it should be remembered that serious adverse reaction could be provoked due to re-exposure to the possibly causative drug. 4 In this study the most prominent clinical type found were fixed drug eruption (FDE), followed by urticaria, and eczematous eruption as presented in Table 1 Patch test is used to identify the causes of exanthematous and pustular drug eruption, FDE, Stevens-Johnsons syndrom (SJS), and toxic epidermal necrolysis (TEN). 3 Theoretically patch testing would give a positive result if there is delayed hypersensitivity or there are sensitized T cells / memory T cells that become numerous in the most severely affected skin. 8, 11 On Table 2 a high positive results of patch test were obtained on patients with eczematous eruption, erythroderma, erythema multiforme, and papular * cited from ref. 9 eruption. Patch test on FDE patients were done on the involved and un-involved skin lesion. [12] [13] [14] In FDE the patch test result gave a higher positive result than the prick test, while in urticaria patients the positive prick test result is higher as expected concerning the underlying pathogenic mechanism. 1 In this study the results of patch test on exanthematous eruption were negative and skin prick test followed the negative patch test showed 50% positive results; this proved that the clinical eruptions are a combination of the different Coombs and Gell reaction type. 1 Other reason is the possibility of metabolite as the cause, which is difficult to trace. Ideally, skin test should be performed with the commercialized drug, and if possible the pure active products and excipient (filler). 3 To performed test with pure active products is another constrained in our study.
The most frequent causative drug are antipyretic (paracetamol, metamizole), and antibiotic (amoxycillin, rifampicin). These drugs are commonly prescribed by the physician. Important skin manifestation of side effects of drugs is based partly on the data of clinical trials, national or international registered of harmful effects of drugs. Difficulties in deciding which side effects are important, eg severe reactions are regarded important even they occur seldom and exanthems subsiding in a few days are also listed important if they occur frequently. In case of newer drug data on side effects is usually sparse that the importance of skin manifestations is not yet established. 15 In a mild form of CADR an oral provocation test were performed with a precaution for a severe reaction (Table 4) . In urticaria patient with positive patch test results, oral provocation test with amoxycillin ¼ and ½ dose gave a positive results. Full dose oral provocation with with paracetamol and piroxicam gave positive result in SPT positive patients. In FDE positive patch test patient oral provocation with tetracyclin ½ dose gave positive result. These results support the role of skin testing in CADR as an alternative to oral provocation test. [3] [4] [5] 9 One of the risk factor for allergic drug eruption is atopy, including asthma bronchiale, allergic rhinitis, or atopic dermatitis. In this study we found that 52.9% of the respondent has history of atopy, either personal, family or both as seen in Table 7 . Atopy was included in the history of CADR since mid of year '98 (total respondent were 697)
CONCLUSION
Skin test could detect the cause of CADR in 34.4% patients.Fixed drug eruption, urticaria and exanthematous eruption were the most common clinical manifestation of drug eruption. Atopic history was found in relative high percentage and could considered as the risk factor of CADR Paracetamol and amoxycilline were the most frequent cause of CADR that could be proven by skin test. Skin test could be used as an alternative for determining the causative drug in CADR, especially in the severe form.
